Almonty Industries: A Wolfram Lifeline Amidst a Semiconductor Squeeze

The global semiconductor industry is facing a raw material time bomb. Japanese suppliers have warned Samsung and SK Hynix that their stocks of tungsten hexafluoride, a critical gas for chip etching, may only last until June 2026. This looming shortage, driven by tightening Chinese export controls, has thrown a harsh spotlight on alternative suppliers. Almonty Industries, with its recently restarted Sangdong mine in South Korea, finds itself positioned as a potential lifeline, geographically and strategically at the heart of the crisis.

Operational momentum is building. Almonty completed the Phase-1 commissioning of the Sangdong facility in March 2026. The processing plant is now operational, designed to handle approximately 640,000 tonnes of ore annually and produce about 2,300 tonnes of tungsten concentrate. This marks the first production from the site in over three decades, transforming long-held promises into tangible output. The company’s upcoming quarterly report in May is expected to provide the first concrete production data from this ramp-up phase.

Financing the operation has involved a series of structured steps, detailed in a recent SEC Form 6-K filing. The document reveals four amendment agreements to a $75.1 million secured term loan for subsidiary Almonty Korea Tungsten Corp., with the agreements spanning from 2023 to 2026. This disclosure outlines the evolving financial foundation for the mine. The company’s cash position has swelled dramatically to CAD $268.4 million, bolstered by capital raises including a July 2025 Nasdaq listing that raised $90 million and a subsequent December 2025 offering generating $129.4 million.

The supply crunch is fueling extraordinary price moves. Following China's significant tightening of export controls in late 2025, the spot price for ammonium paratungstate (APT) surged 534% by mid-March 2026 to $2,250 per tonne. This inflationary pressure is already visible in Almonty's financials. Fourth-quarter 2025 revenue jumped 39% to CAD $8.7 million, contributing to full-year 2025 revenue growth of 13% to CAD $32.5 million.

Should investors sell immediately? Or is it worth buying Almonty?

Analysts are taking note of the shifting landscape. Recent weeks have seen a series of price target upgrades. B. Riley Financial raised its target from $17.00 to $23.00, while Oppenheimer increased its target from $16.00 to $19.00. DA Davidson reaffirmed a $25.00 target in late March. Currently, four out of five analysts covering the stock rate it a 'Buy'.

Almonty's growth plan is two-pronged. At Sangdong, a Phase-2 expansion slated for 2027 aims to double ore processing capacity to roughly 1.2 million tonnes per year. At full run-rate, the mine could supply an estimated 40% of the world's tungsten demand outside of China. Simultaneously, the company is developing a North American foothold with its Gentung-Browns Lake project in Montana. Targeting production readiness in the second half of 2026, the project is estimated to have an annual capacity of roughly 140,000 metric tonne units. This aligns with a U.S. defense mandate requiring contractors to source tungsten exclusively from non-Chinese suppliers starting January 1, 2027. A long-term offtake agreement with U.S. processor Global Tungsten & Powders is already in place.

The strategic importance of these assets is attracting institutional capital. The number of institutional funds holding Almonty shares increased by more than 55% last quarter, reaching 107. Van Eck Associates now holds a significant position of 11.2 million shares valued at approximately $99 million.

Almonty at a turning point? This analysis reveals what investors need to know now.

With chipmakers reportedly shortening or bypassing the lengthy qualification process for new suppliers, the pressure for secure, non-Chinese tungsten is acute. BMO analysts forecast a continued supply deficit for 2026, noting no short-term mechanism exists to resolve the bottleneck as Western alternative supply chains remain years away from meaningful capacity. As Almonty prepares for its Annual General Meeting on June 8, where Phase-2 expansion details are likely to be discussed, the company's ability to scale production will be under intense scrutiny from both investors and a desperate global industry.

Ad

Almonty Stock: New Analysis - 13 April

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

en | CA0203981034 | ALMONTY | boerse | 69140477 |